$12.9MSeed, 11 June 2025
Seed to discover and optimize small molecules against the Elk1 target and validate biomarkers.
- Amount
- $12.9M
- Stage
- Seed
- Announced
- 11 June 2025
- Lead
- Kurma Partners
- Other investors
- WE Life Sciences, French Tech Seed (Bpifrance), Argobio, Angelini Ventures, CARMA Fund, Capital Grand Est, Sambrinvest
- Use of funds
- Seed to discover and optimize small molecules against the Elk1 target and validate biomarkers.
- Checked
- Amount and date checked against the press source
- Source
- Elkedonia closes EUR 11.3 million seed round for neuroplastogen depression treatments startupbusiness.it